LP
AGN

Longview Partners’s Allergan plc AGN Stock Holding History

Longview Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,010,929
Closed -$887M – 27
2020
Q1 		$887M Sell
5,010,929
-1,898,505
-27% -$357M 4.78% 10
2019
Q4 		$1.32B Sell
6,909,434
-71,602
-1% -$12.9M 5.53% 11
2019
Q3 		$1.17B Sell
6,981,036
-5,530
-0.1% -$901K 5.47% 11
2019
Q2 		$1.17B Buy
6,986,566
+676,771
+11% +$93.7M 5.67% 8
2019
Q1 		$924M Buy
6,309,795
+283,687
+5% +$41.1M 4.87% 13
2018
Q4 		$805M Buy
6,026,108
+4,475,447
+289% +$734M 4.29% 14
2018
Q3 		$295M Sell
1,550,661
-20,270
-1% -$3.72M 1.46% 24
2018
Q2 		$262M Buy
1,570,931
+580,808
+59% +$93.2M 1.36% 24
2018
Q1 		$167M Buy
+990,123
New +$166M 0.87% 25

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Longview Partners's AGN Position: Q2 2020 in Review

Longview Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,010,929 shares — an estimated $887M sold.

Longview Partners first reported a position in AGN in Q1 2018 and held it in 9 quarters. The position peaked at $1.32B in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Longview Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Longview Partners sold 5,010,929 Allergan plc shares in Q2 2020, an estimated $887M.
  • Longview Partners first reported a position in Allergan plc in Q1 2018 and held it in 9 quarters.
  • Longview Partners's Allergan plc position peaked at $1.32B in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Longview Partners's 13F filing for Q2 2020, filed 14 Aug 2020.